首页 > 最新文献

International Journal of Critical Illness and Injury Science最新文献

英文 中文
Refractory pancytopenia upon initiation of asciminib in tyrosine kinase inhibitor-resistant chronic myeloid leukemia. 酪氨酸激酶抑制剂耐药的慢性粒细胞白血病中ascimib引发的难治性全血细胞减少症。
Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-06-26 DOI: 10.4103/ijciis.ijciis_85_22
Steven Tessier, Mina Aiad, Santo Longo, Melissa Wilson, Yacoub Faroun

Asciminib, a "Specifically Targeting the ABL Myristoyl Pocket" inhibitor, is a new drug in the treatment of tyrosine kinase inhibitor (TKI)-resistant chronic myeloid leukemia (CML). Hemocytopenias associated with asciminib are common adverse events documented by clinical trials. We report a case of precipitous-onset pancytopenia with the initiation of asciminib treatment in a patient with TKI-resistant CML. This case had a confounding array of laboratory findings that evidenced a drug-induced hemophagocytic component. We hope that our case stimulates further reporting of similar cases to enhance the understanding of the pathophysiology underlying asciminib-induced hemocytopenias.

Asciminib是一种“特异性靶向ABL Myristoyl口袋”抑制剂,是一种治疗酪氨酸激酶抑制剂(TKI)耐药性慢性粒细胞白血病(CML)的新药。与腹水相关的血细胞减少症是临床试验记录的常见不良事件。我们报告了一例TKI耐药CML患者在开始腹水治疗后突然出现的全血细胞减少症。该病例有一系列令人困惑的实验室发现,证明了药物诱导的噬血细胞成分。我们希望我们的病例能刺激类似病例的进一步报道,以增强对腹水诱导的血细胞减少症的病理生理学的理解。
{"title":"Refractory pancytopenia upon initiation of asciminib in tyrosine kinase inhibitor-resistant chronic myeloid leukemia.","authors":"Steven Tessier,&nbsp;Mina Aiad,&nbsp;Santo Longo,&nbsp;Melissa Wilson,&nbsp;Yacoub Faroun","doi":"10.4103/ijciis.ijciis_85_22","DOIUrl":"10.4103/ijciis.ijciis_85_22","url":null,"abstract":"<p><p>Asciminib, a \"Specifically Targeting the ABL Myristoyl Pocket\" inhibitor, is a new drug in the treatment of tyrosine kinase inhibitor (TKI)-resistant chronic myeloid leukemia (CML). Hemocytopenias associated with asciminib are common adverse events documented by clinical trials. We report a case of precipitous-onset pancytopenia with the initiation of asciminib treatment in a patient with TKI-resistant CML. This case had a confounding array of laboratory findings that evidenced a drug-induced hemophagocytic component. We hope that our case stimulates further reporting of similar cases to enhance the understanding of the pathophysiology underlying asciminib-induced hemocytopenias.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 2","pages":"78-81"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9953335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of adherence with lung-protective ventilator strategies in moderate-to-severe acute respiratory distress syndrome in a tertiary care setup in India: A prospective observational study. 印度三级医疗机构对中重度急性呼吸窘迫综合征患者肺保护性呼吸机策略依从性的评估:一项前瞻性观察性研究。
Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-06-26 DOI: 10.4103/ijciis.ijciis_66_22
Simran J Singh, Alex Jude Fonseca, Spandan Rajyaguru

Background: Evaluation of the efficacy and safety of mechanical ventilation settings is a cornerstone of the early phase of the management of acute respiratory distress syndrome (ARDS). This study aimed to evaluate the adherence to currently recommended lung-protective ventilator strategies (tidal volume, plateau pressure, driving pressure, prone positioning, and positive end-expiratory pressure [PEEP]) for adults with moderate-to-severe ARDS in a tertiary care setup, thereby evaluating if lung-protective ventilation is associated with improved outcomes.

Methods: This was an observational study over 1 year in ventilated moderate-to-severe ARDS participants. All participants were mechanically ventilated when required using the protocol followed by the ARDS Network low-tidal volume lung-protective ventilation strategy and monitored.

Results: The total number of participants in the study was 32. Septic shock was the most common cause of ARDS. The mean duration of intensive care unit (ICU) stay was 6.13 (±5.4) days, mean ventilator days were 3.66 (±3.75) days and mortality rate of 71.8%.Adherence to low-tidal volume was 78.12% with an improvement of 36% in the adherent group (P = 0.06). Adherence to high PEEP was 34.38% with a survival of 73% in the adherent group (P = 0.0004). Adherence to prone ventilation was 18.75% with a survival of 33% in the adherent group (P = 0.7).

Conclusion: Intensivists should take an extra effort to focus on evidence-based ventilator strategies and increase adherence to these recommendations in their ICUs to improve patient survival.

背景:评估机械通气装置的疗效和安全性是急性呼吸窘迫综合征(ARDS)早期治疗的基石。本研究旨在评估在三级护理机构中,中度至重度ARDS成人对目前推荐的肺保护性通气策略(潮气量、平台压力、驱动压力、俯卧位和呼气末正压[PEEP])的依从性,从而评估肺保护性通风是否与改善结果相关。方法:这是一项为期1年的观察性研究,研究对象为通气性中重度ARDS参与者。所有参与者在需要时使用ARDS网络低潮气量肺保护性通气策略进行机械通气,并进行监测。结果:参与研究的总人数为32人。败血症休克是ARDS最常见的病因。重症监护室(ICU)的平均住院时间为6.13(±5.4)天,平均通气天数为3.66(±3.75)天,死亡率为71.8%。坚持低潮气量组为78.12%,改善36%(P=0.06)。坚持高PEEP组为34.38%,存活73%(P=0.0004)。坚持俯卧通气组为18.75%,存活33%(P=0.07)加倍努力,专注于循证呼吸机策略,并在重症监护室中增加对这些建议的遵守,以提高患者的生存率。
{"title":"Evaluation of adherence with lung-protective ventilator strategies in moderate-to-severe acute respiratory distress syndrome in a tertiary care setup in India: A prospective observational study.","authors":"Simran J Singh,&nbsp;Alex Jude Fonseca,&nbsp;Spandan Rajyaguru","doi":"10.4103/ijciis.ijciis_66_22","DOIUrl":"10.4103/ijciis.ijciis_66_22","url":null,"abstract":"<p><strong>Background: </strong>Evaluation of the efficacy and safety of mechanical ventilation settings is a cornerstone of the early phase of the management of acute respiratory distress syndrome (ARDS). This study aimed to evaluate the adherence to currently recommended lung-protective ventilator strategies (tidal volume, plateau pressure, driving pressure, prone positioning, and positive end-expiratory pressure [PEEP]) for adults with moderate-to-severe ARDS in a tertiary care setup, thereby evaluating if lung-protective ventilation is associated with improved outcomes.</p><p><strong>Methods: </strong>This was an observational study over 1 year in ventilated moderate-to-severe ARDS participants. All participants were mechanically ventilated when required using the protocol followed by the ARDS Network low-tidal volume lung-protective ventilation strategy and monitored.</p><p><strong>Results: </strong>The total number of participants in the study was 32. Septic shock was the most common cause of ARDS. The mean duration of intensive care unit (ICU) stay was 6.13 (±5.4) days, mean ventilator days were 3.66 (±3.75) days and mortality rate of 71.8%.Adherence to low-tidal volume was 78.12% with an improvement of 36% in the adherent group (<i>P</i> = 0.06). Adherence to high PEEP was 34.38% with a survival of 73% in the adherent group (<i>P</i> = 0.0004). Adherence to prone ventilation was 18.75% with a survival of 33% in the adherent group (<i>P</i> = 0.7).</p><p><strong>Conclusion: </strong>Intensivists should take an extra effort to focus on evidence-based ventilator strategies and increase adherence to these recommendations in their ICUs to improve patient survival.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 2","pages":"60-65"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9953329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of spirituality on patient memories of intensive care unit stays: A nationwide cross-sectional study. 精神对重症监护病房住院患者记忆的影响:一项全国性的横断面研究。
Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-06-26 DOI: 10.4103/ijciis.ijciis_10_23
Amir Vahedian-Azimi, Mahmood Salesi, Ali A Hssain, Farzaneh Baghernezhad, Andrew C Miller

Background: Absent or delusional memories are experienced by many patients following an intensive care unit (ICU) stay. Up to 70% may have delusional or hallucinatory intrusive memories, which may persist long term. This study aims to investigate how spiritual health (SH) impacts ICU patients' memories and quality of communication (QoC) between patients and physicians (PP) or nurses (PN).

Methods: This cross-sectional study was conducted across the country on ICU patients discharged from 45 medical centers in 31 provinces of Iran, to evaluate the direct and indirect effects of SH and ICU characteristics on patients' memory. Two valid and standard ICU memory tools (ICU-MT) and SH questionnaires were administered to patients 1 day post-ICU discharge used.

Results: No significant direct effect of SH scores on ICU-MT items was observed. No significant correlation was observed between PP-QoC and PN-QoC variables and primary items of the ICU-MT. Female sex positively correlated with the development of delusional memories (odds ratio [OR]: 1.730, 95% confidence interval [CI]: 1.025-2.915, P < 0.05). Subjects admitted to the medical ICU were less likely to remember being in the ICU (OR: 0.398, 95% CI: 0.159-0.996, P < 0.05), and were less likely to report intrusive memories from their time in the hospital or events that led to their admission (OR: 0.19, 95% CI: 0.086-0.419, P < 0.001).

Conclusions: The results of this study indicate that the spiritual health indirectly increased coping with intrusive memories, however, no direct effect was observed on ICU-MT items. The quality of communication between patients and physicians and nurses significantly mediated development of intrusive memories.

背景:许多患者在重症监护室(ICU)住院后都会出现无记忆或妄想记忆。高达70%的人可能有妄想或幻觉侵入性记忆,这种记忆可能会长期存在。本研究旨在调查精神健康(SH)如何影响ICU患者的记忆以及患者与医生(PP)或护士(PN)之间的沟通质量(QoC),评估SH和ICU特征对患者记忆的直接和间接影响。使用两种有效且标准的ICU记忆工具(ICU-MT)和SH问卷对ICU出院后1天的患者进行调查。结果:SH评分对ICU-MT项目无明显直接影响。在PP生活质量和PN生活质量变量以及ICU-MT的主要项目之间没有观察到显著的相关性。女性与妄想记忆的发展呈正相关(比值比[OR]:1.730,95%置信区间[CI]:1.025-2.915,P<0.05)。入住医疗ICU的受试者不太可能记得自己在ICU(OR:0.398,95%CI:0.15-0.996,P<0.05),并且不太可能报告他们住院期间的侵入性记忆或导致他们入院的事件(or:0.19,95%CI:0.086-0.419,P<0.001)。结论:本研究的结果表明,精神健康间接增加了对侵入性记忆的应对,但对ICU-MT项目没有观察到直接影响。患者与医生和护士之间的沟通质量显著介导了侵入性记忆的发展。
{"title":"Impact of spirituality on patient memories of intensive care unit stays: A nationwide cross-sectional study.","authors":"Amir Vahedian-Azimi,&nbsp;Mahmood Salesi,&nbsp;Ali A Hssain,&nbsp;Farzaneh Baghernezhad,&nbsp;Andrew C Miller","doi":"10.4103/ijciis.ijciis_10_23","DOIUrl":"10.4103/ijciis.ijciis_10_23","url":null,"abstract":"<p><strong>Background: </strong>Absent or delusional memories are experienced by many patients following an intensive care unit (ICU) stay. Up to 70% may have delusional or hallucinatory intrusive memories, which may persist long term. This study aims to investigate how spiritual health (SH) impacts ICU patients' memories and quality of communication (QoC) between patients and physicians (PP) or nurses (PN).</p><p><strong>Methods: </strong>This cross-sectional study was conducted across the country on ICU patients discharged from 45 medical centers in 31 provinces of Iran, to evaluate the direct and indirect effects of SH and ICU characteristics on patients' memory. Two valid and standard ICU memory tools (ICU-MT) and SH questionnaires were administered to patients 1 day post-ICU discharge used.</p><p><strong>Results: </strong>No significant direct effect of SH scores on ICU-MT items was observed. No significant correlation was observed between PP-QoC and PN-QoC variables and primary items of the ICU-MT. Female sex positively correlated with the development of delusional memories (odds ratio [OR]: 1.730, 95% confidence interval [CI]: 1.025-2.915, <i>P</i> < 0.05). Subjects admitted to the medical ICU were less likely to remember being in the ICU (OR: 0.398, 95% CI: 0.159-0.996, <i>P</i> < 0.05), and were less likely to report intrusive memories from their time in the hospital or events that led to their admission (OR: 0.19, 95% CI: 0.086-0.419, <i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>The results of this study indicate that the spiritual health indirectly increased coping with intrusive memories, however, no direct effect was observed on ICU-MT items. The quality of communication between patients and physicians and nurses significantly mediated development of intrusive memories.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 2","pages":"66-72"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9955796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trend of mortality rate due to traffic accidents in Iran from 2006 to 2020: A cross-sectional study. 2006年至2020年伊朗交通事故死亡率趋势:一项横断面研究。
Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-06-26 DOI: 10.4103/ijciis.ijciis_58_22
Saeed Erfanpoor, Jalil Hasani, Seyed Davood Mirtorabi, Reza Haj Manouchehri, Seyed Saeed Hashemi Nazari

Background: Traffic accidents are a common global cause of mortality and physical disability. This study aimed to investigate traffic accident-related mortality trends across provinces in Iran.

Methods: In this study, information on all deaths caused by traffic accidents in Iran from 2006 to 2020 was collected from the Iranian Legal Medicine Organization, which collects annual data from all 31 Iranian provinces. The national and provincial demographics were assessed, and the trends in mortality rates were assessed over a 15-year span using joinpoint regression based on the log-linear model, with results expressed in terms of annual percentage change (APC). The analysis for the trend was performed using the Joinpoint Regression Program 4.9.0.1.

Results: During the study period, 291,774 traffic accident-related deaths occurred in Iran, of which 78.6% were men and 21.4% were women. The mean age of the deceased was 37.75 ± 20.89 years. The mortality rate has dropped from 39/100,000 in 2006 to 18.3/100,000 in 2020. In total, the national mortality rate APC for 2006-2015 was -6.3% (P < 0.05) and for 2015-2020 was - 1.70% (P > 0.05).

Conclusions: Despite the overall decreasing national trend in Iran's traffic accident-related mortality over the study period, the provincial variability was noted. Therefore, it seems necessary to design and conduct epidemiological studies in different areas and provinces, for a better and more accurate understanding of the factors affecting the occurrence of traffic accident-related deaths, resulting in more focused and measurable interventions.

背景:交通事故是全球常见的死亡和身体残疾原因。本研究旨在调查伊朗各省与交通事故相关的死亡率趋势。方法:本研究从伊朗法律医学组织收集了2006年至2020年伊朗所有交通事故造成的死亡信息,该组织收集了伊朗所有31个省的年度数据。评估了全国和省级人口统计数据,并使用基于对数线性模型的连接点回归评估了15年内的死亡率趋势,结果以年度百分比变化(APC)表示。使用Joinpoint回归程序4.9.0.1对趋势进行分析。结果:在研究期间,伊朗发生了291774例交通事故相关死亡,其中78.6%为男性,21.4%为女性。死者平均年龄为37.75±20.89岁。死亡率已从2006年的39/10万下降到2020年的18.3/10万。总的来说,2006-2015年的全国死亡率APC为-6.3%(P<0.05),2015-2020年为-170%(P>0.05)。因此,似乎有必要在不同地区和省份设计和进行流行病学研究,以便更好、更准确地了解影响交通事故相关死亡发生的因素,从而采取更有针对性和可衡量的干预措施。
{"title":"Trend of mortality rate due to traffic accidents in Iran from 2006 to 2020: A cross-sectional study.","authors":"Saeed Erfanpoor,&nbsp;Jalil Hasani,&nbsp;Seyed Davood Mirtorabi,&nbsp;Reza Haj Manouchehri,&nbsp;Seyed Saeed Hashemi Nazari","doi":"10.4103/ijciis.ijciis_58_22","DOIUrl":"10.4103/ijciis.ijciis_58_22","url":null,"abstract":"<p><strong>Background: </strong>Traffic accidents are a common global cause of mortality and physical disability. This study aimed to investigate traffic accident-related mortality trends across provinces in Iran.</p><p><strong>Methods: </strong>In this study, information on all deaths caused by traffic accidents in Iran from 2006 to 2020 was collected from the Iranian Legal Medicine Organization, which collects annual data from all 31 Iranian provinces. The national and provincial demographics were assessed, and the trends in mortality rates were assessed over a 15-year span using joinpoint regression based on the log-linear model, with results expressed in terms of annual percentage change (APC). The analysis for the trend was performed using the Joinpoint Regression Program 4.9.0.1.</p><p><strong>Results: </strong>During the study period, 291,774 traffic accident-related deaths occurred in Iran, of which 78.6% were men and 21.4% were women. The mean age of the deceased was 37.75 ± 20.89 years. The mortality rate has dropped from 39/100,000 in 2006 to 18.3/100,000 in 2020. In total, the national mortality rate APC for 2006-2015 was -6.3% (<i>P</i> < 0.05) and for 2015-2020 was - 1.70% (<i>P</i> > 0.05).</p><p><strong>Conclusions: </strong>Despite the overall decreasing national trend in Iran's traffic accident-related mortality over the study period, the provincial variability was noted. Therefore, it seems necessary to design and conduct epidemiological studies in different areas and provinces, for a better and more accurate understanding of the factors affecting the occurrence of traffic accident-related deaths, resulting in more focused and measurable interventions.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 2","pages":"73-77"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9950099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective evaluation of dexmedetomidine dosing in a cohort of neurologically injured obese critically ill patients. 神经损伤肥胖危重患者队列中右美托咪定给药的回顾性评价。
Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-06-26 DOI: 10.4103/ijciis.ijciis_74_22
Harrison He, Sara A Atyia, Keaton S Smetana, Casey C May

Background: Dexmedetomidine is used in neurocritical care units (NCCUs) due to the light, dose-dependent sedation, and anxiolysis provided. It is unknown how to dose dexmedetomidine in obese patients. The primary objective is to assess the ability to achieve the goal Richmond Agitation Sedation Scale (RASS) measurements in obese patients with a neurological injury who are solely on dexmedetomidine before and after an institutional dosing change from actual body weight (ABW) to adjusted body weight (AdjBW).

Methods: This study included patients admitted to the NCCU with a neurological condition, required dexmedetomidine for at least 8 h as a sole sedative, and weighed ≥120% of ideal body weight. Percentage of RASS measurements within the goal range (-1 to +1) during the first 48 h while on dexmedetomidine were compared between patients dosed on ABW and on AdjBW.

Results: Sixty-eight patients in the ABW cohort and 72 patients in the AdjBW cohort were included. There were no statistical differences between the two groups (ABW vs. AdjBW) in the percent of RASS measurements in the goal range (53.2% ± 34.8% vs. 55% ± 37%; P = 0.78), mean weight (99.2 ± 26 vs. 96.8 ± 20.9 kg; P = 0.55), or the average dose of dexmedetomidine required to achieve first goal RASS score (0.4 ± 0.3 vs. 0.4 ± 0.3 mcg/kg/h; P = 0.98).

Conclusions: Dosing dexmedetomidine using AdjBW in obese critically ill neurologically injured patients for ongoing sedation resulted in no statistical difference in the percent of RASS measurements within the goal when compared to ABW dosing. Further studies are warranted.

背景:右美托咪定用于神经重症监护室(NCCU),因为它具有光照、剂量依赖性镇静和抗焦虑作用。目前尚不清楚如何给肥胖患者服用右美托咪定。主要目的是评估在从实际体重(ABW)到调整体重(AdjBW)的机构给药前后仅服用右美托咪定的患有神经损伤的肥胖患者实现Richmond激动镇静量表(RASS)测量目标的能力,需要右美托咪定作为唯一的镇静剂至少8小时,体重≥理想体重的120%。比较服用ABW和AdjBW的患者在服用右美托咪定的前48小时内RASS测量值在目标范围(-1至+1)内的百分比。结果:包括ABW队列中的68名患者和AdjBW队列中的72名患者。两组(ABW与AdjBW)在目标范围内的RASS测量百分比(53.2%±34.8%与55%±37%;P=0.78)、平均体重(99.2±26与96.8±20.9kg;P=0.55)、,或达到第一个目标RASS评分所需的右美托咪定的平均剂量(0.4±0.3 vs.0.4±0.3 mcg/kg/h;P=0.098)。需要进一步研究。
{"title":"Retrospective evaluation of dexmedetomidine dosing in a cohort of neurologically injured obese critically ill patients.","authors":"Harrison He,&nbsp;Sara A Atyia,&nbsp;Keaton S Smetana,&nbsp;Casey C May","doi":"10.4103/ijciis.ijciis_74_22","DOIUrl":"10.4103/ijciis.ijciis_74_22","url":null,"abstract":"<p><strong>Background: </strong>Dexmedetomidine is used in neurocritical care units (NCCUs) due to the light, dose-dependent sedation, and anxiolysis provided. It is unknown how to dose dexmedetomidine in obese patients. The primary objective is to assess the ability to achieve the goal Richmond Agitation Sedation Scale (RASS) measurements in obese patients with a neurological injury who are solely on dexmedetomidine before and after an institutional dosing change from actual body weight (ABW) to adjusted body weight (AdjBW).</p><p><strong>Methods: </strong>This study included patients admitted to the NCCU with a neurological condition, required dexmedetomidine for at least 8 h as a sole sedative, and weighed ≥120% of ideal body weight. Percentage of RASS measurements within the goal range (-1 to +1) during the first 48 h while on dexmedetomidine were compared between patients dosed on ABW and on AdjBW.</p><p><strong>Results: </strong>Sixty-eight patients in the ABW cohort and 72 patients in the AdjBW cohort were included. There were no statistical differences between the two groups (ABW vs. AdjBW) in the percent of RASS measurements in the goal range (53.2% ± 34.8% vs. 55% ± 37%; <i>P</i> = 0.78), mean weight (99.2 ± 26 vs. 96.8 ± 20.9 kg; <i>P</i> = 0.55), or the average dose of dexmedetomidine required to achieve first goal RASS score (0.4 ± 0.3 vs. 0.4 ± 0.3 mcg/kg/h; <i>P</i> = 0.98).</p><p><strong>Conclusions: </strong>Dosing dexmedetomidine using AdjBW in obese critically ill neurologically injured patients for ongoing sedation resulted in no statistical difference in the percent of RASS measurements within the goal when compared to ABW dosing. Further studies are warranted.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 2","pages":"48-53"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9950562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
What's New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity. 危重症和损伤科学有什么新进展?权衡右美托咪定在肥胖危重患者中给药的证据。
Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-06-26 DOI: 10.4103/ijciis.ijciis_25_23
Rana Hejal, Andrea Popa, Maribel Llamas Rangel, Kenneth E Remy
{"title":"What's New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity.","authors":"Rana Hejal, Andrea Popa, Maribel Llamas Rangel, Kenneth E Remy","doi":"10.4103/ijciis.ijciis_25_23","DOIUrl":"10.4103/ijciis.ijciis_25_23","url":null,"abstract":"","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 2","pages":"45-47"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9955802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of a pharmacist-based toxicology consult service on appropriate use of intravenous N-acetylcysteine for acetaminophen toxicity: A retrospective cohort study. 基于药剂师的毒理学咨询服务对静脉注射N-乙酰半胱氨酸治疗对乙酰氨基酚毒性的影响:一项回顾性队列研究。
Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-06-26 DOI: 10.4103/ijciis.ijciis_88_22
Jonathan A Summerlin, Kellie M Wang, Andre J McMahon, Jeremy A Lund

Background: Incorporating clinical pharmacists on the medical team has been associated with fewer medication errors and increased error interception. Due to the logistical complexities of the intravenous (IV) N-acetylcysteine (NAC) regimen for acetaminophen toxicity, many opportunities for medication errors exist. A pharmacist-based toxicology consultation service was implemented at our institution, allowing pharmacists to formally aid in the management of toxicology patients throughout their hospital admission, including those with acetaminophen toxicity. The purpose of this study was to evaluate the effect of a house-wide pharmacist-based toxicology consult service on errors associated with IV NAC treatment for patients admitted with acetaminophen toxicity.

Methods: A retrospective, pre-post cohort study was conducted on patients who received IV NAC for acetaminophen toxicity. The intervention evaluated was the implementation of a pharmacist-based toxicology consult service, known as the pharmacy toxicology team. The primary end point was the incidence of an error associated with IV NAC. An error was defined as the composite of inappropriate dose, administration rate, initiation, continuation, or discontinuation.

Results: Eighty-four patients were included; 30 patients in the pregroup, and 54 patients in the postgroup. Fewer patients experienced an error in the postgroup compared to the pregroup (30% vs 63%, P = 0.003).

Conclusion: The implementation of this unique pharmacist-based toxicology consult service was associated with fewer patients experiencing an error related to IV NAC therapy for acetaminophen toxicity. Application of this data may aid in the justification for development of clinical pharmacist-based toxicology consult services at other institutions.

背景:将临床药剂师纳入医疗团队与减少用药错误和增加错误拦截有关。由于静脉注射(IV)N-乙酰半胱氨酸(NAC)方案治疗对乙酰氨基酚毒性的后勤复杂性,存在许多药物错误的机会。我们机构实施了基于药剂师的毒理学咨询服务,允许药剂师在毒理学患者入院期间正式协助管理,包括对乙酰氨基酚中毒患者。本研究的目的是评估基于药剂师的毒理学咨询服务对因对乙酰氨基酚毒性入院的患者静脉注射NAC治疗相关错误的影响。方法:对因对乙酰氨基酚毒性而接受静脉注射NAC的患者进行回顾性前后队列研究。评估的干预措施是实施基于药剂师的毒理学咨询服务,即药学毒理学团队。主要终点是与静脉注射NAC相关的错误发生率。错误被定义为不适当的剂量、给药率、开始、持续或停药的组合。结果:纳入84例患者;前组30例,后组54例。与前组相比,后组出现错误的患者更少(30%对63%,P=0.003)。结论:实施这种独特的基于药剂师的毒理学咨询服务,与较少的患者出现与对乙酰氨基酚毒性静脉注射NAC治疗相关的错误有关。这些数据的应用可能有助于证明在其他机构发展基于临床药剂师的毒理学咨询服务的合理性。
{"title":"Effect of a pharmacist-based toxicology consult service on appropriate use of intravenous N-acetylcysteine for acetaminophen toxicity: A retrospective cohort study.","authors":"Jonathan A Summerlin,&nbsp;Kellie M Wang,&nbsp;Andre J McMahon,&nbsp;Jeremy A Lund","doi":"10.4103/ijciis.ijciis_88_22","DOIUrl":"10.4103/ijciis.ijciis_88_22","url":null,"abstract":"<p><strong>Background: </strong>Incorporating clinical pharmacists on the medical team has been associated with fewer medication errors and increased error interception. Due to the logistical complexities of the intravenous (IV) N-acetylcysteine (NAC) regimen for acetaminophen toxicity, many opportunities for medication errors exist. A pharmacist-based toxicology consultation service was implemented at our institution, allowing pharmacists to formally aid in the management of toxicology patients throughout their hospital admission, including those with acetaminophen toxicity. The purpose of this study was to evaluate the effect of a house-wide pharmacist-based toxicology consult service on errors associated with IV NAC treatment for patients admitted with acetaminophen toxicity.</p><p><strong>Methods: </strong>A retrospective, pre-post cohort study was conducted on patients who received IV NAC for acetaminophen toxicity. The intervention evaluated was the implementation of a pharmacist-based toxicology consult service, known as the pharmacy toxicology team. The primary end point was the incidence of an error associated with IV NAC. An error was defined as the composite of inappropriate dose, administration rate, initiation, continuation, or discontinuation.</p><p><strong>Results: </strong>Eighty-four patients were included; 30 patients in the pregroup, and 54 patients in the postgroup. Fewer patients experienced an error in the postgroup compared to the pregroup (30% vs 63%, <i>P</i> = 0.003).</p><p><strong>Conclusion: </strong>The implementation of this unique pharmacist-based toxicology consult service was associated with fewer patients experiencing an error related to IV NAC therapy for acetaminophen toxicity. Application of this data may aid in the justification for development of clinical pharmacist-based toxicology consult services at other institutions.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 2","pages":"54-59"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401558/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9950095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the effects of tranexamic acid, nitroglycerin, and remifentanil on the prevention of bleeding during herniated lumbar intervertebral disc surgery: A randomized clinical trial. 氨甲环酸、硝酸甘油和瑞芬太尼预防腰椎间盘突出症手术出血效果的比较:一项随机临床试验。
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-03-24 DOI: 10.4103/ijciis.ijciis_40_22
Hesameddin Modir, Esmail Moshiri, Aidin Shakeri, Mohamad Khalatbari

Background: Surgery is a well-known and effective method of treating lumbar intervertebral disc herniation. The present study aimed to compare the effects of administering tranexamic acid (TXA), nitroglycerin (NTG), and remifentanil (REF) on hemorrhage prevention during herniated lumbar intervertebral disc surgery.

Methods: A double-blind clinical trial was conducted on 135 participants undergoing lumbar intervertebral disc surgery. A randomized block design was used for subject assignment to three groups including TXA, NTG, and REF. The hemodynamic parameters, bleeding rate, hemoglobin level, and the amount of infused propofol were measured and recorded after surgery. Data were then analyzed in SPSS software using Chi-square test and analysis of variance.

Results: The mean age of participants in the study was 42.12 ± 7.93 years, and all three groups were equal in terms of demographic characteristics (P > 0.05). The mean arterial pressure (MAP) of the TXA and NTG groups was notably higher than the REF group (P < 0.008). The mean heart rate (HR) of the TXA and NTG groups was notably higher than the REF group (P < 0.05). The propofol dosage used in the TXA group was higher than the two groups of NTG and REF (P < 0.001).

Conclusion: Among participants undergoing lumbar intervertebral disc surgery, the greatest MAP variability was observed in the NTG group. Higher mean HR and propofol consumption was observed in the NTG and TXA groups when compared to REF. No statistically significant differences were noted between groups in oxygen saturation or bleeding risk. Based on these findings, REF may be considered a preferred surgical adjunct over TXA and NTG during lumbar intervertebral disc surgery.

背景:手术是治疗腰椎间盘突出症的一种众所周知的有效方法。本研究旨在比较氨甲环酸(TXA)、硝酸甘油(NTG)和瑞芬太尼(REF)在腰椎间盘突出症手术中预防出血的效果。方法:对135名腰椎间盘手术患者进行双盲临床试验。采用随机分组设计将受试者分为三组,包括TXA、NTG和REF。术后测量并记录血液动力学参数、出血率、血红蛋白水平和输注丙泊酚的量。然后在SPSS软件中使用卡方检验和方差分析对数据进行分析。结果:研究参与者的平均年龄为42.12±7.93岁,TXA组和NTG组的平均动脉压(MAP)显著高于REF组(P<0.008),TXA组、NTG组平均心率(HR)显著高于EF组(P>0.05)结论:在接受腰椎间盘手术的参与者中,NTG组的MAP变异性最大。与REF相比,NTG和TXA组的平均HR和丙泊酚消耗量更高。两组之间的血氧饱和度或出血风险没有统计学上的显著差异。基于这些发现,在腰椎间盘手术中,REF可能被认为是TXA和NTG的首选手术辅助手段。
{"title":"Comparison of the effects of tranexamic acid, nitroglycerin, and remifentanil on the prevention of bleeding during herniated lumbar intervertebral disc surgery: A randomized clinical trial.","authors":"Hesameddin Modir,&nbsp;Esmail Moshiri,&nbsp;Aidin Shakeri,&nbsp;Mohamad Khalatbari","doi":"10.4103/ijciis.ijciis_40_22","DOIUrl":"10.4103/ijciis.ijciis_40_22","url":null,"abstract":"<p><strong>Background: </strong>Surgery is a well-known and effective method of treating lumbar intervertebral disc herniation. The present study aimed to compare the effects of administering tranexamic acid (TXA), nitroglycerin (NTG), and remifentanil (REF) on hemorrhage prevention during herniated lumbar intervertebral disc surgery.</p><p><strong>Methods: </strong>A double-blind clinical trial was conducted on 135 participants undergoing lumbar intervertebral disc surgery. A randomized block design was used for subject assignment to three groups including TXA, NTG, and REF. The hemodynamic parameters, bleeding rate, hemoglobin level, and the amount of infused propofol were measured and recorded after surgery. Data were then analyzed in SPSS software using Chi-square test and analysis of variance.</p><p><strong>Results: </strong>The mean age of participants in the study was 42.12 ± 7.93 years, and all three groups were equal in terms of demographic characteristics (<i>P</i> > 0.05). The mean arterial pressure (MAP) of the TXA and NTG groups was notably higher than the REF group (<i>P</i> < 0.008). The mean heart rate (HR) of the TXA and NTG groups was notably higher than the REF group (<i>P</i> < 0.05). The propofol dosage used in the TXA group was higher than the two groups of NTG and REF (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Among participants undergoing lumbar intervertebral disc surgery, the greatest MAP variability was observed in the NTG group. Higher mean HR and propofol consumption was observed in the NTG and TXA groups when compared to REF. No statistically significant differences were noted between groups in oxygen saturation or bleeding risk. Based on these findings, REF may be considered a preferred surgical adjunct over TXA and NTG during lumbar intervertebral disc surgery.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 1","pages":"18-25"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9461398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common obstetrics and gynecologic topics in critical care: A narrative review. 危重症护理中常见的产科和妇科话题:叙述性综述。
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-03-24 DOI: 10.4103/ijciis.ijciis_20_22
Julia Ritchie, Meredith L Birsner, Israel Zighelboim, Nicholas P Taylor

The fields of Obstetrics and Gynecology and Critical Care often share medically and surgically complex patients. Peripartum anatomic and physiologic changes can predispose or exacerbate certain conditions and rapid action is often needed. This review discusses some of the most common conditions responsible for the admission of obstetrical and gynecological patients to the critical care unit. We will consider both obstetrical and gynecologic concepts including postpartum hemorrhage, antepartum hemorrhage, abnormal uterine bleeding, preeclampsia and eclampsia, venous thromboembolism, amniotic fluid embolism, sepsis and septic shock, obstetrical trauma, acute abdomen, malignancies, peripartum cardiomyopathy, and substance abuse. This article aims to be a primer for the Critical Care provider.

妇产科和重症监护领域经常有复杂的医学和外科患者。围产期的解剖和生理变化可能会导致或加剧某些情况,通常需要迅速采取行动。这篇综述讨论了产科和妇科患者进入重症监护室的一些最常见的情况。我们将考虑产科和妇科的概念,包括产后出血、产前出血、异常子宫出血、先兆子痫和子痫、静脉血栓栓塞、羊水栓塞、败血症和感染性休克、产科创伤、急腹症、恶性肿瘤、围产期心肌病和药物滥用。本文旨在为重症监护提供者提供入门知识。
{"title":"Common obstetrics and gynecologic topics in critical care: A narrative review.","authors":"Julia Ritchie,&nbsp;Meredith L Birsner,&nbsp;Israel Zighelboim,&nbsp;Nicholas P Taylor","doi":"10.4103/ijciis.ijciis_20_22","DOIUrl":"10.4103/ijciis.ijciis_20_22","url":null,"abstract":"<p><p>The fields of Obstetrics and Gynecology and Critical Care often share medically and surgically complex patients. Peripartum anatomic and physiologic changes can predispose or exacerbate certain conditions and rapid action is often needed. This review discusses some of the most common conditions responsible for the admission of obstetrical and gynecological patients to the critical care unit. We will consider both obstetrical and gynecologic concepts including postpartum hemorrhage, antepartum hemorrhage, abnormal uterine bleeding, preeclampsia and eclampsia, venous thromboembolism, amniotic fluid embolism, sepsis and septic shock, obstetrical trauma, acute abdomen, malignancies, peripartum cardiomyopathy, and substance abuse. This article aims to be a primer for the Critical Care provider.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"13 1","pages":"38-43"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9461402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium 危重疾病和损伤科学有什么新进展?应用S100β诊断危重患者谵妄并进行危险分层的证据与局限性
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.4103/ijciis.ijciis_51_23
AndrewC Miller
Delirium is a transient fluctuating global disorder of cognition associated with increased morbidity and mortality and has a prevalence of up to 80% among intensive care unit (ICU) patients.[1–3] ICU delirium may be a predictor of increased complications, prolonged ICU and non-ICU hospital length of stay (LOS), increased hospital costs, long-term disability, long-term cognitive impairment, decreased odds of discharge home, and increased hospital mortality.[1] Moreover, ICU delirium has been associated with the development of incident neuropsychiatric disorders, including depression, anxiety, trauma, stress-related disorders, and neurocognitive disorders.[4] However, clinical management has been limited by the lack of an effective, reliable, and readily available biomarker to aid in the diagnosis, severity, and prognosis, and to aid clinical management. S100b protein is a calcium-binding protein that is mainly found in astrocytes and oligodendrocytes of the central nervous system and Schwann cells of the peripheral nervous system.[5] As such, S100β has been investigated as a biomarker for injury to the blood–brain barrier and/or astrocyte injury and has been reported to correlate with the degree of blood–brain barrier destruction and the severity and scope of brain injury.[5–7] Previously, S100β has been correlated with the development of delirium and cognitive changes after surgery in patients who are not critically ill.[6,8–11] Similarly, others have reported that delirium and neurologic outcomes may correlate with S100β in critically ill patients.[6,7,12–14] However, there are significant limitations and gaps in the available literature. The current studies display a predominance of male subjects (up to 65%), advanced age, and low levels of racial diversity among the study groups.[6,7,12–17] All current studies among critically ill populations have all been performed in China (n = 3),[5,12,13] the United States (n = 2),[6,7] Belgium (n = 2),[14,15] the Netherlands (n = 1),[17] or Brazil (n = 1).[16] Furthermore, limitations in study design limit the generalizability of the reported findings, including small sample sizes, differences in the study group populations (trauma vs. medical), differences in illness severity as evidenced by wide ranges on validated illness severity indices, and an absence of randomized studies (e.g. only observational and case–control studies).[5–7,12–17] In addition, the comparability of the preillness baseline health of the study populations across studies is unclear as only the US studies have reported a validated index for this (e.g. the Charlson Comorbidity Index).[5–7,12–17] Among the ICU populations, S100β levels have been reported to positively correlate with ICU LOS and readmission (trauma populations),[5,13] and adverse outcomes (mixed medical/surgical, trauma populations).[13,14] In addition, S100B was negatively correlated with global cognition up to 12 months after hospital discharge in a mixed medical/surg
谵妄是一种与发病率和死亡率增加相关的短暂性波动性整体认知障碍,在重症监护病房(ICU)患者中患病率高达80%。[1 - 3] ICU谵妄可能是并发症增加、ICU和非ICU住院时间延长、住院费用增加、长期残疾、长期认知障碍、出院回家几率降低和住院死亡率增加的预测因素。[1]此外,ICU谵妄与神经精神疾病的发生有关,包括抑郁、焦虑、创伤、压力相关疾病和神经认知障碍。[4]然而,临床管理由于缺乏有效、可靠和容易获得的生物标志物来帮助诊断、严重程度和预后,以及帮助临床管理而受到限制。S100b蛋白是一种钙结合蛋白,主要存在于中枢神经系统的星形胶质细胞和少突胶质细胞以及周围神经系统的雪旺细胞中。[5]因此,S100β已被研究作为血脑屏障损伤和/或星形胶质细胞损伤的生物标志物,并被报道与血脑屏障破坏程度和脑损伤的严重程度和范围相关。[5-7]先前,S100β与非危重患者手术后谵妄和认知变化的发展有关。[6,8 - 11]同样,其他人也报道了危重患者的谵妄和神经系统预后可能与S100β相关。[6,7,12 - 14]然而,在现有文献中存在明显的局限性和空白。目前的研究显示男性受试者占主导地位(高达65%),年龄较大,研究小组中的种族多样性水平较低。[6,7,12 - 17]目前在危重症人群中进行的所有研究均在中国(n = 3)、[5,12,13]美国(n = 2)、[6,7]比利时(n = 2)、[14,15]荷兰(n = 1)、[17]或巴西(n = 1)进行。[16]此外,研究设计的局限性限制了报告结果的普遍性,包括样本量小、研究组人群的差异(创伤与医疗)、疾病严重程度的差异(经验证的疾病严重程度指数范围大)以及缺乏随机研究(例如,只有观察性和病例对照研究)。[5 - 7,12 - 17]此外,各研究中研究人群的病前基线健康状况的可比性尚不清楚,因为只有美国的研究报告了一个有效的指数(例如Charlson共病指数)。[5 - 7,12 - 17]在ICU人群中,据报道S100β水平与ICU LOS和再入院(创伤人群),[5,13]和不良结局(混合医疗/手术,创伤人群)呈正相关。[13,14]此外,在内科/外科混合ICU人群中,S100B与出院后12个月的整体认知呈负相关;然而,没有观察到执行功能的差异。[6]尽管有这些发现,关于谵妄的数据却参差不齐。在医学和外科混合人群中,S100β与谵妄发生率(n = 134)、谵妄持续时间(7,14)和死亡率相关(阳性或无)的报道各不相同。[5,16]值得注意的是,这些研究要么排除了孕妇,要么没有报道孕妇。在最新一期的《国际危重疾病与损伤科学杂志》上,Shyam等人通过评估年轻女性南亚产科人口,解决了重要的知识差距。[18]Shyam等人对印度危重产科患者的S100β水平进行了巢式病例对照研究(n = 112)。在这项研究中,S100β与谵妄水平呈正相关。[18]尽管结果令人鼓舞,但仍需要在更大、更多样化的(种族和临床)人群中进行进一步的前瞻性研究,以建立区分阈值和S100β在诊断和预后方面的临床应用,或指导危重谵妄患者的临床管理。研究质量和伦理声明本报告不需要机构审查委员会/伦理委员会的批准。作者遵循适用的EQUATOR网络(http://www.equator- network.org/)指南;然而,没有针对社论的具体指导方针。
{"title":"What's New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium","authors":"AndrewC Miller","doi":"10.4103/ijciis.ijciis_51_23","DOIUrl":"https://doi.org/10.4103/ijciis.ijciis_51_23","url":null,"abstract":"Delirium is a transient fluctuating global disorder of cognition associated with increased morbidity and mortality and has a prevalence of up to 80% among intensive care unit (ICU) patients.[1–3] ICU delirium may be a predictor of increased complications, prolonged ICU and non-ICU hospital length of stay (LOS), increased hospital costs, long-term disability, long-term cognitive impairment, decreased odds of discharge home, and increased hospital mortality.[1] Moreover, ICU delirium has been associated with the development of incident neuropsychiatric disorders, including depression, anxiety, trauma, stress-related disorders, and neurocognitive disorders.[4] However, clinical management has been limited by the lack of an effective, reliable, and readily available biomarker to aid in the diagnosis, severity, and prognosis, and to aid clinical management. S100b protein is a calcium-binding protein that is mainly found in astrocytes and oligodendrocytes of the central nervous system and Schwann cells of the peripheral nervous system.[5] As such, S100β has been investigated as a biomarker for injury to the blood–brain barrier and/or astrocyte injury and has been reported to correlate with the degree of blood–brain barrier destruction and the severity and scope of brain injury.[5–7] Previously, S100β has been correlated with the development of delirium and cognitive changes after surgery in patients who are not critically ill.[6,8–11] Similarly, others have reported that delirium and neurologic outcomes may correlate with S100β in critically ill patients.[6,7,12–14] However, there are significant limitations and gaps in the available literature. The current studies display a predominance of male subjects (up to 65%), advanced age, and low levels of racial diversity among the study groups.[6,7,12–17] All current studies among critically ill populations have all been performed in China (n = 3),[5,12,13] the United States (n = 2),[6,7] Belgium (n = 2),[14,15] the Netherlands (n = 1),[17] or Brazil (n = 1).[16] Furthermore, limitations in study design limit the generalizability of the reported findings, including small sample sizes, differences in the study group populations (trauma vs. medical), differences in illness severity as evidenced by wide ranges on validated illness severity indices, and an absence of randomized studies (e.g. only observational and case–control studies).[5–7,12–17] In addition, the comparability of the preillness baseline health of the study populations across studies is unclear as only the US studies have reported a validated index for this (e.g. the Charlson Comorbidity Index).[5–7,12–17] Among the ICU populations, S100β levels have been reported to positively correlate with ICU LOS and readmission (trauma populations),[5,13] and adverse outcomes (mixed medical/surgical, trauma populations).[13,14] In addition, S100B was negatively correlated with global cognition up to 12 months after hospital discharge in a mixed medical/surg","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135596436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Critical Illness and Injury Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1